GeneDx Holdings Corp. Interest Paid, Excluding Capitalized Interest, Operating Activities
GeneDx Holdings Corp. (WGS) reported Interest Paid, Excluding Capitalized Interest, Operating Activities of $3.81 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaidNet · last filed 2026-08-03
- GeneDx Holdings Corp. interest paid, excluding capitalized interest, operating activities for the quarter ending 2026-06-30 was $2.06M, a 28.26% increase year-over-year.
- GeneDx Holdings Corp. interest paid, excluding capitalized interest, operating activities for the quarter ending 2026-03-31 was $1.75M, a 9.25% increase year-over-year.
- GeneDx Holdings Corp. interest paid, excluding capitalized interest, operating activities for the quarter ending 2025-12-31 was $1.58M, a 3.90% decline year-over-year.
- GeneDx Holdings Corp. interest paid, excluding capitalized interest, operating activities for the quarter ending 2025-09-30 was $1.63M, a 62.18% increase year-over-year.
- GeneDx Holdings Corp. interest paid, excluding capitalized interest, operating activities for fiscal 2025 was $6.41M, a 3.95% decline from fiscal 2024.
- GeneDx Holdings Corp. interest paid, excluding capitalized interest, operating activities for fiscal 2024 was $6.68M, a 119.57% increase from fiscal 2023.
- GeneDx Holdings Corp. interest paid, excluding capitalized interest, operating activities for fiscal 2023 was $3.04M, a 57.40% increase from fiscal 2022.
- GeneDx Holdings Corp. interest paid, excluding capitalized interest, operating activities for fiscal 2022 was $1.93M, a 29.77% decline from fiscal 2021.
| Period end | Interest Paid, Excluding Capitalized Interest, Operating Activities 3 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 6 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 9 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 9 month as first filed | Interest Paid, Excluding Capitalized Interest, Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $3.81M 10-Q · filed 2026-08-03 | $5.39M derived: sum of 3 quarters · filed 2026-08-03 | $7.02M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2026-03-31 | $1.75M 10-Q · filed 2026-05-04 | $3.33M derived: sum of 2 quarters · filed 2026-05-04 | $4.95M derived: sum of 3 quarters · filed 2026-05-04 | $6.56M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $3.20M derived: sum of 2 quarters · filed 2026-02-23 | $4.81M derived: sum of 3 quarters · filed 2026-08-03 | $6.41M 10-K · filed 2026-02-23 | |
| 2025-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $3.23M derived: sum of 2 quarters · filed 2026-08-03 | $4.83M 10-Q · filed 2025-10-28 | $6.48M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-06-30 | $1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $3.21M 10-Q · filed 2026-08-03 | $4.85M derived: sum of 3 quarters · filed 2026-08-03 | $5.85M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-03-31 | $1.60M 10-Q · filed 2026-05-04 | $3.24M derived: sum of 2 quarters · filed 2026-05-04 | $4.24M derived: sum of 3 quarters · filed 2026-05-04 | $6.26M derived: sum of 4 quarters · filed 2026-05-04 | |
| 2024-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $2.64M derived: sum of 2 quarters · filed 2026-02-23 | $4.66M derived: sum of 3 quarters · filed 2026-02-23 | $6.68M 10-K · filed 2026-02-23 | |
| 2024-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $3.02M derived: sum of 2 quarters · filed 2025-10-28 | $5.04M 10-Q · filed 2025-10-28 | $6.07M 10-Q · filed 2024-10-29 | $6.96M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $4.03M 10-Q · filed 2025-07-29 | $5.96M derived: sum of 3 quarters · filed 2026-02-23 | $6.13M derived: sum of 4 quarters · filed 2026-02-23 | |
| 2024-03-31 | $2.02M 10-Q · filed 2025-04-30 | $3.94M derived: sum of 2 quarters · filed 2026-02-23 | $4.11M derived: sum of 3 quarters · filed 2026-02-23 | $4.48M derived: sum of 4 quarters · filed 2026-02-23 | |
| 2023-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $2.10M derived: sum of 2 quarters · filed 2026-02-23 | $2.46M derived: sum of 3 quarters · filed 2026-02-23 | $3.04M 10-K · filed 2026-02-23 | |
| 2023-09-30 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $533.00K derived: sum of 2 quarters · filed 2024-10-29 | $1.12M 10-Q · filed 2024-10-29 | $1.25M derived: sum of 4 quarters · filed 2024-10-29 | |
| 2023-06-30 | $363.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $946.00K 10-Q · filed 2024-07-30 | $1.08M derived: sum of 3 quarters · filed 2024-07-30 | $1.69M derived: sum of 4 quarters · filed 2024-07-30 | |
| 2023-03-31 | $583.00K 10-Q · filed 2024-04-29 | $720.00K derived: sum of 2 quarters · filed 2024-04-29 | $1.32M derived: sum of 3 quarters · filed 2024-04-29 | $1.91M derived: sum of 4 quarters · filed 2024-04-29 | |
| 2022-12-31 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $739.00K derived: sum of 2 quarters · filed 2024-02-23 | $1.32M derived: sum of 3 quarters · filed 2024-02-23 | $1.93M 10-K · filed 2024-02-23 | |
| 2022-09-30 | $602.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $1.19M derived: sum of 2 quarters · filed 2023-11-03 | $1.79M 10-Q · filed 2023-11-03 | $2.42M derived: sum of 4 quarters · filed 2023-11-03 | |
| 2022-06-30 | $586.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.19M 10-Q · filed 2023-08-08 | $1.82M derived: sum of 3 quarters · filed 2023-08-08 | $2.50M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $607.00K 10-Q · filed 2023-05-09 | $1.23M derived: sum of 2 quarters · filed 2023-05-09 | $1.91M derived: sum of 3 quarters · filed 2023-05-09 | $2.63M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $623.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.31M derived: sum of 2 quarters · filed 2023-03-16 | $2.03M derived: sum of 3 quarters · filed 2023-03-16 | $2.75M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $683.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.41M derived: sum of 2 quarters · filed 2022-11-14 | $2.13M 10-Q · filed 2022-11-14 | $2.05M derived: sum of 4 quarters · filed 2023-03-16 | |
| 2021-06-30 | $722.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.45M 10-Q · filed 2022-08-15 | $1.36M derived: sum of 3 quarters · filed 2023-03-16 | ||
| 2021-03-31 | $723.00K 10-Q · filed 2022-05-12 | $642.00K derived: sum of 2 quarters · filed 2023-03-16 | |||
| 2020-12-31 | -$81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.75M 10-K · filed 2023-03-16 | |||
| 2020-09-30 | $1.83M 10-Q · filed 2021-11-15 | ||||
| 2019-12-31 | $305.00K 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |